Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
Recap by typeshit. Post by Andrew D. Huberman, Ph.D. on X.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
Loading…